Search the Community
Showing results for tags 'English'.
Found 90 results
-
What a vaccine scientist facing angry anti-vaxxers wishes he had said
Brian posted a resource in Media / Press Releases
Opinion news article of a vaccine scientist being confronted by anti-vaxxers during his book launch. Photo: Dr. Paul A. Offit, M.D., is a professor of pediatrics and the director of the Vaccine Education Center at Children's Hospital of Philadelphia. -
Building the capacity to improve vaccine acceptance and uptake through the curation of evidence based resources. CANVax makes it easier for public health professionals to find and collect resources to inform their work in improving vaccine acceptance and uptake.
-
Whether you are a government regulator, a scientist, or a health care provider, the Vaccine Safety Quarterly has relevant vaccine safety information for you. It is a newsletter for our friends, partners, and members. It highlights opinions from the world’s leading vaccine safety experts, gives you a description of new projects and stories and opinions from our members and reports on our work’s impact. It will help you stay informed and offer ways to get involved.
-
Dengue fever is present in Asia, the Pacific, the Caribbean, the Americas and Africa. Humans are infected with dengue virus through bites of tiger (Aedes) mosquitoes. There are 4 different dengue types, and infection with one type gives little immune protection against the other types. After an incubation of 8-10 days, a mild and usually self-limited flu-like illness develops. Current scientific evidence shows that sequential infection increases the risk of a severe form of the infection with bleedings - dengue hemorrhagic fever. In several Asian countries, dengue hemorrhagic fever has become an important cause of disease and death, mainly in children. No specific treatment or vaccine exists for dengue, and general intensive care is often needed.
-
The relations between vaccine hesitancy (VH) and individual socioeconomic status (SES) vary with context and remain poorly understood. We examined associations between parental SES and VH levels and their potential mediation by two attitudinal factors: commitment to making “good” health-related decisions and trust in mainstream medicine. Vaccine refusal and delay are frequent among French parents, especially the more educated. Our results suggest that levels of commitment and trust play a key role in shaping VH. Suitable educational interventions are needed to restore trust in authorities and vaccines. Helping healthcare professionals to communicate better with vaccine-hesitant parents is also essential. -
First annual report from the AusVaxSafety national surveillance system
Smaragda posted a resource in Reports
AusVaxSafety is a national system for monitoring vaccine safety in Australia. The first annual report from AusVaxSafety summarises information from parents and carers who responded to an SMS about their child's health a few days after receiving a vaccine at routine National Immunisation Program schedule points in 2016-17. The report includes infographics providing a visual representation of the information collected through those responses, including the number of parents and carers who responded and health information about their children. A separate infographic summarises responses from parents and carers of Aboriginal and Torres Strait Islander children, who receive additional vaccines at the 12 and 18 month schedule points. The results confirm that vaccines in the National Immunisation Program are safe. -
"Adolescent Immunization Update and the 16-Year-Old Platform"
Smaragda posted a resource in Events & webinars
Presenter: Sharon G. Humiston, MD, MPH September 2018 -
Update on Maternal Immunization: Universal Tdap for Pregnant Women in Canada
Smaragda posted a resource in Events & webinars
Presented by: the Society of Obstetricians and Gynaecologists of Canada Date: 28 March 2018 Speaker: Dr. Vanessa Poliquin -
Extensive section providing information to help parents to decide whether to immunize their child with the measles-maps-rubella (MMR) vaccine. It comprises an Introduction; a section dedicated to symptoms of the three diseases; 3 FAQs regarding the vaccine, its safety and the impact of MMR vaccination; comparisons of the risks for each of the diseases; a section helping making a decision and sections FOR and for NOT vaccinating the child. Moreover links to access organizations for and against the vaccination are provided and finally a table is given so that the parent decides what to do. Finally additional references are provided for more information.
-
MMR decision aid and Dealing with requests for vaccination exemption
-
Promote the importance of immunizations with this communications toolkit This toolkit was created to promote the importance of immunizations during National Immunization Awareness Month (NIAM), which occurs every August. We encourage you to use the valuable resources in this toolkit throughout the year. The 2018 edition of the toolkit contains key messages, vaccine information, sample news releases and articles, sample social media messages, links to web resources from CDC and other organizations, and logos, web banners, posters and graphics to use with social media. It also includes a media outreach toolkit and a place for you to share your NIAM activities and view what other are doing for NIAM. (#NIAM18) Use the toolkit to design your own promotions. Mix and match, copy or adapt the contents to fit the particular news and issues of your own organization or community - and share your NIAM activities to inspire others. For more information, please contact Tom Schafer at tschafer@nphic.org The National Public Health Information Coalition is the premier network of public health communicators in the United States and U.S. territories. They are committed to "making public health public" by sharing our knowledge, expertise and resources to effectively communicate about the important health issues of the day.
-
ECDC infographics about dengue fever
-
A fact sheet about how vaccines are shown to be safe, noting how all vaccines are carefully tested.
-
OBSERVED RATE OF VACCINE REACTIONS VARICELLA ZOSTER VIRUS VACCINE
Smaragda posted a resource in Fact-sheets
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS VARICELLA ZOSTER VIRUS VACCINE -
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS TYPHOID VACCINE
-
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS ROTAVIRUS VACCINE
-
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS RABIES VACCINE
-
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS POLIO VACCINES
-
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS PNEUMOCOCCAL VACCINE
-
OBSERVED RATE OF VACCINE REACTIONS MEASLES, MUMPS AND RUBELLA VACCINES
Smaragda posted a resource in Fact-sheets
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS MEASLES, MUMPS AND RUBELLA VACCINES -
OBSERVED RATE OF VACCINE REACTIONS JAPANESE ENCEPHALITIS VACCINE
Smaragda posted a resource in Fact-sheets
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS JAPANESE ENCEPHALITIS VACCINE -
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS INFLUENZA VACCINE
-
OBSERVED RATE OF VACCINE REACTIONS HUMAN PAPILLOMA VIRUS VACCINE
Smaragda posted a resource in Fact-sheets
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS HUMAN PAPILLOMA VIRUS VACCINE -
OBSERVED RATE OF VACCINE REACTIONS HAEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINE
Smaragda posted a resource in Fact-sheets
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS HAEMOPHILUS INFLUENZAE TYPE B (HIB) VACCINE -
INFORMATION SHEET OBSERVED RATE OF VACCINE REACTIONS HEPATITIS B VACCINE
